Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

help with creating a balance sheet!!! Forecast income Statement and Balance Sheet Followng are the income statement and balance sheet for Medtronic PLC Note: Complete

help with creating a balance sheet!!! image text in transcribed
image text in transcribed
image text in transcribed
image text in transcribed
image text in transcribed
image text in transcribed
Forecast income Statement and Balance Sheet Followng are the income statement and balance sheet for Medtronic PLC Note: Complete the entire question using the following Excel template: Excel Template. Then enter the answers into the provided spaces below with two decimal places. Medtronic PLC Consolidated Balance Sheet $ millions April 26, 2019 \begin{tabular}{|l|r|} \hline Current assets \\ \hline Cash and cash equivalents \\ \hline Investments & $4,393 \\ \hline Accounts receivable, net & 5,455 \\ \hline Inventories, net & 6,222 \\ \hline Other current assets & 3,753 \\ \hline Total current assets & 900 \\ \hline Property, plant, and equipment, net & 20,723 \\ \hline Goodwill & 4,675 \\ \hline Other intangible assets, net & 39,959 \\ \hline Tax assets & 20,560 \\ \hline Other assets & 638 \\ \hline Total assets & 1,014 \\ \hline Current liabilities & $87,569 \\ \hline Current debt obligations & $838 \\ \hline Accounts payable & 1,953 \\ \hline Accrued compensation & 2,189 \\ \hline Accrued income taxes & 567 \\ \hline Other accrued expenses & 2,925 \\ \hline Total current liabilities & 8,472 \\ \hline Long-term debt & 24,486 \\ \hline Accrued compensation and retirement benefits & 1,651 \\ \hline Accrued income taxes & 2,838 \\ \hline Deferred tax liabilities & 1,278 \\ \hline \end{tabular} \begin{tabular}{|l|r|} \hline Total liabilities & 39,043 \\ \hline Shareholders' equity & 0 \\ \hline Ordinary shares & 24,846 \\ \hline Additional paid-in capital & 26,270 \\ \hline Retained earnings & (2,711) \\ \hline Accumulated other comprehensive loss & 48,405 \\ \hline Total shareholders' equity & 121 \\ \hline Noncontrolling interests & 48,526 \\ \hline Total equity & $87,569 \\ \hline Total liabilities and equity & \end{tabular} \begin{tabular}{|c|c|c|} \hline Investments & & No change \\ \hline Accounts receivable, less allowance & 20.4% & of net sales \\ \hline Inventories, net & 12.3% & of net sales \\ \hline Other current assets & 7% & of net sales \\ \hline Goodwill & & No change \\ \hline Tax assets & 5% & of net sales \\ \hline Other assets & 3.3% & of net sales \\ \hline Accounts payable & 6.4% & of net sales \\ \hline Accrued compensation (current liability) & 7.2% & of net sales \\ \hline Accrued compensation and retirement benefits (noncurrent liability) & a & No change \\ \hline Accrued income taxes (current liability) & 1.9% & of net sales \\ \hline Other accrued expenses & 9.6% & of net sales \\ \hline Accrued income taxes (noncurrent liability) & 9.3% & of net sales \\ \hline Deferred tax liabilities & 4.2% & of net sales \\ \hline Other liabilities & 2.5% & of net sales \\ \hline Ordinary shares & X & No change \\ \hline Accumulated other comprehensive loss & & No change \\ \hline Net income attributable to noncontrolling interest. & $19 & million \\ \hline Dividends in FY2020 & $2,853 & million \\ \hline CAPEX in FY2019 & $1,134 & Smillion, forecast CAPEX at historic % of net sales \\ \hline Depreciation expense in Fy2020 & $950 & miltion \\ \hline Amortization expense in Fy2020 & $1.914 & million \\ \hline Debt due in FY2020 & $838 & million \\ \hline Debt due in FY2021 & $2,058 & million \\ \hline \end{tabular} Medtronic PLC Consolidated Balance Sheet $ millions 2020 \begin{tabular}{|c|c|c|} \hline Current assets & & \\ \hline Cash and cash equivalents & $ & 4,393 \\ \hline Investments & & 5,455 \\ \hline Accounts receivable, net & & 16,290.83 \\ \hline Inventories, net & & 3,758.51 \\ \hline Other current assets & & 916.71 \\ \hline Total current assets & & 20,723 \\ \hline Property, plant, and equipment, net & & 4,675 \\ \hline Goodwill & & 39,959 \\ \hline Other intangible assets, net & & 916.71 \\ \hline Tax assets & & 0 \\ \hline Other assets & & 0 \\ \hline Total assets & $ & 0 \\ \hline Current liabilities & & \\ \hline Current debt obligations & $ & 0 \\ \hline Accounts payable & & 0 \\ \hline Accrued compensation & & 0 \\ \hline Accrued income taxes & & 0 \\ \hline Other accrued expenses & & 0 \\ \hline Total current liabilities & & 0 \\ \hline Long-term debt & & 0 \\ \hline Accrued compensation and retirement benefits & & 0 \\ \hline Accrued income taxes & & 0 \\ \hline Deferred tax liabilities & & 0 \\ \hline Oth & & 0x \\ \hline \end{tabular} \begin{tabular}{|c|c|} \hline Other liabilities & 0 \\ \hline Total liabilities & 0 \\ \hline \multicolumn{2}{|l|}{ Shareholders' equity } \\ \hline Ordinary shares & 0 \\ \hline Additional paid-in capital & 02 \\ \hline Retained earnings & 0x \\ \hline Accumulated other comprehensive loss & 0x \\ \hline Total shareholders' equity & 0x \\ \hline Noncontrolling interests & 0 \\ \hline Total equity & 0 \\ \hline Total liabilities and equity & 0 \\ \hline \end{tabular} Forecast income Statement and Balance Sheet Followng are the income statement and balance sheet for Medtronic PLC Note: Complete the entire question using the following Excel template: Excel Template. Then enter the answers into the provided spaces below with two decimal places. Medtronic PLC Consolidated Balance Sheet $ millions April 26, 2019 \begin{tabular}{|l|r|} \hline Current assets \\ \hline Cash and cash equivalents \\ \hline Investments & $4,393 \\ \hline Accounts receivable, net & 5,455 \\ \hline Inventories, net & 6,222 \\ \hline Other current assets & 3,753 \\ \hline Total current assets & 900 \\ \hline Property, plant, and equipment, net & 20,723 \\ \hline Goodwill & 4,675 \\ \hline Other intangible assets, net & 39,959 \\ \hline Tax assets & 20,560 \\ \hline Other assets & 638 \\ \hline Total assets & 1,014 \\ \hline Current liabilities & $87,569 \\ \hline Current debt obligations & $838 \\ \hline Accounts payable & 1,953 \\ \hline Accrued compensation & 2,189 \\ \hline Accrued income taxes & 567 \\ \hline Other accrued expenses & 2,925 \\ \hline Total current liabilities & 8,472 \\ \hline Long-term debt & 24,486 \\ \hline Accrued compensation and retirement benefits & 1,651 \\ \hline Accrued income taxes & 2,838 \\ \hline Deferred tax liabilities & 1,278 \\ \hline \end{tabular} \begin{tabular}{|l|r|} \hline Total liabilities & 39,043 \\ \hline Shareholders' equity & 0 \\ \hline Ordinary shares & 24,846 \\ \hline Additional paid-in capital & 26,270 \\ \hline Retained earnings & (2,711) \\ \hline Accumulated other comprehensive loss & 48,405 \\ \hline Total shareholders' equity & 121 \\ \hline Noncontrolling interests & 48,526 \\ \hline Total equity & $87,569 \\ \hline Total liabilities and equity & \end{tabular} \begin{tabular}{|c|c|c|} \hline Investments & & No change \\ \hline Accounts receivable, less allowance & 20.4% & of net sales \\ \hline Inventories, net & 12.3% & of net sales \\ \hline Other current assets & 7% & of net sales \\ \hline Goodwill & & No change \\ \hline Tax assets & 5% & of net sales \\ \hline Other assets & 3.3% & of net sales \\ \hline Accounts payable & 6.4% & of net sales \\ \hline Accrued compensation (current liability) & 7.2% & of net sales \\ \hline Accrued compensation and retirement benefits (noncurrent liability) & a & No change \\ \hline Accrued income taxes (current liability) & 1.9% & of net sales \\ \hline Other accrued expenses & 9.6% & of net sales \\ \hline Accrued income taxes (noncurrent liability) & 9.3% & of net sales \\ \hline Deferred tax liabilities & 4.2% & of net sales \\ \hline Other liabilities & 2.5% & of net sales \\ \hline Ordinary shares & X & No change \\ \hline Accumulated other comprehensive loss & & No change \\ \hline Net income attributable to noncontrolling interest. & $19 & million \\ \hline Dividends in FY2020 & $2,853 & million \\ \hline CAPEX in FY2019 & $1,134 & Smillion, forecast CAPEX at historic % of net sales \\ \hline Depreciation expense in Fy2020 & $950 & miltion \\ \hline Amortization expense in Fy2020 & $1.914 & million \\ \hline Debt due in FY2020 & $838 & million \\ \hline Debt due in FY2021 & $2,058 & million \\ \hline \end{tabular} Medtronic PLC Consolidated Balance Sheet $ millions 2020 \begin{tabular}{|c|c|c|} \hline Current assets & & \\ \hline Cash and cash equivalents & $ & 4,393 \\ \hline Investments & & 5,455 \\ \hline Accounts receivable, net & & 16,290.83 \\ \hline Inventories, net & & 3,758.51 \\ \hline Other current assets & & 916.71 \\ \hline Total current assets & & 20,723 \\ \hline Property, plant, and equipment, net & & 4,675 \\ \hline Goodwill & & 39,959 \\ \hline Other intangible assets, net & & 916.71 \\ \hline Tax assets & & 0 \\ \hline Other assets & & 0 \\ \hline Total assets & $ & 0 \\ \hline Current liabilities & & \\ \hline Current debt obligations & $ & 0 \\ \hline Accounts payable & & 0 \\ \hline Accrued compensation & & 0 \\ \hline Accrued income taxes & & 0 \\ \hline Other accrued expenses & & 0 \\ \hline Total current liabilities & & 0 \\ \hline Long-term debt & & 0 \\ \hline Accrued compensation and retirement benefits & & 0 \\ \hline Accrued income taxes & & 0 \\ \hline Deferred tax liabilities & & 0 \\ \hline Oth & & 0x \\ \hline \end{tabular} \begin{tabular}{|c|c|} \hline Other liabilities & 0 \\ \hline Total liabilities & 0 \\ \hline \multicolumn{2}{|l|}{ Shareholders' equity } \\ \hline Ordinary shares & 0 \\ \hline Additional paid-in capital & 02 \\ \hline Retained earnings & 0x \\ \hline Accumulated other comprehensive loss & 0x \\ \hline Total shareholders' equity & 0x \\ \hline Noncontrolling interests & 0 \\ \hline Total equity & 0 \\ \hline Total liabilities and equity & 0 \\ \hline \end{tabular}

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Financial Accounting Tools For Business Decision Making

Authors: Paul D. Kimmel, Jerry J. Weygandt, Donald E. Kieso, Barbara Trenholm, Wayne Irvine, Christopher D. Burnley

8th Canadian Edition

111959457X, 978-1119594574

More Books

Students also viewed these Accounting questions